Association Between the Magnitude of Glycemic Control and Body Weight Loss With Glp-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses of Randomized Diabetes Cardiovascular Outcomes Trials